Combined oral contraception and treatment of new coronavirus infection (COVID-19): drug interaction issues

Combined oral contraception and treatment of new coronavirus infection (COVID-19): issues of drug interaction This article examines the interaction of combined oral contraceptives with drugs recommended in the treatment of new coronavirus infection (COVID-19) at the pharmacodynamic and pharmacokinetic levels, with an assessment of the effectiveness and safety of therapy for the female body.

1. WHO. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. 13 March 2020. Accessed April 20, 2020. Available at: https://www.who.int/publicationsdetail/clinical-management-of-severe-acuterespiratory-infection-whennovel-coronavirus-(ncov)-infection-issuspected

2. Jin JM, Bai P, He W et al. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152. DOI: 10.3389/fpubh.2020.00152

3. Adamyan LV, Aznaurova YaB, Filippov OS. COVID-19 and women’s health (literature review). Problemy Reproduktsii (Russian Journal of Human Reproduction). 2020;26(2):6-17. (In Russ).] DOI: 10.17116/repro2020260216

4. Vremennye metodicheskie rekomendacii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19)». Version 9 (26.10.2020). (In Russ).] https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/550/original/%D0%9C%D0%A0_COVID-19_%28v9%29.pdf?1603788097

5. Instructions for the medical use of the drug Belara. №: П N014429/01 от 24.12.08. Bessrochno. Data pereregistracii: 30.09.19. (In Russ).]. Доступно по: https://www.vidal.ru/drugs/belara__2719

6. Kolbin AS. COVID-19 and clinical pharmacology. Clinical pharmacology and therapy. 2020;29(3):14-24. (In Russ).

7. Vyshkovsky GL. Registr lekarstvennyh sredstv Rossii. RLS Enciklopediya lekarstv. Moscow: RLS-PATENT; issue 20/2012. (In Russ).

8. Vyshkovsky GL. Registr lekarstvennyh sredstv. Электронная энциклопедия лекарств. 2020. (In Russ).Доступно по: https://rlsnet/ cсылка активна на 15.12.2020

9. Kukes VG. Klinicheskaya farmakologiya : uchebnik / Ed by VG Kukes, DA Sychev. 5-e izd., ispr. i dop. Moscow: GEOTAR-Media, 2017. (In Russ).] ISBN 978-5-9704-4196-1

10. Finding definitions in a time of uncertainty. A pandemic in the practice of a gynecologist. [Internet]. Gedeon Richter. (In Russ).] Доступно по: https://doctor.g-richter.ru/specprojects/poisk-opredeleniy-vo-vremya-neopredelennosti-pandemiyav-praktike-ginekologa/ cсылка активна на 12.12.2020.

11. Romanenkova JS, Kuzminova TI, Kyzymko MI. Effect of combined oral contraceptives on women with migraine. Obstetrics, gynecology and reproduction [Akusherstvo, ginekologiya i reproduktsiya]. 2018;12(1):86-92. (In Russ).] DOI: 10.17749/2313-7347.2018.12.1.086-092

12. Unanyan AL, Arakelov SE et al. Dysmenorrhea: Practical Issues of Pathogenesis, Clinical Presentation and Treatment. Doctor.Ru Gynecology Endocrinology.2014:1(89):13-17. (In Russ).

13. Driggin E, Madhavan MV, Bikdeli B et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. DOI: 10.1016/j.jacc.2020.03.031.

14. Tang N, Bai H, Chen X et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. DOI: 10.1111/jth.14817.

15. Gromova OA, Torshin IYu, Malyavskaia SI, Lapochkina NP. About the prospects of using vitamin D and other micronutrients in the prevention and therapy of COVID-19. RMJ. 2020;(9):32-38. (In Russ).]

16. Gromova OA, Torshin IYu. The importance of zinc in maintaining the activity of antiviral innate immunity proteins: analysis of publications on COVID-19. The Russian Journal of Preventive Medicine. 2020;23(3):131–139. (In Russ).] DOI: 10.17116/profmed20202303113

17. Gromova OA, Torshin IYu, Uchaykin VF. Micronutrients supporting innate immunity against coronaviruses: results of a systematic computer analysis of publications on COVID-19 and human proteome antiviral proteins. Pharmacology & Pharmacotherapy. 2020;(1):9-25. (In Russ).] DOI: 00110.46393/2713-2129_2020_1_9